Literature DB >> 32034071

HDL and pancreatic β cells: a SMO-king gun?

Liam R Brunham1.   

Abstract

Mesh：

Year:  2020        PMID： 32034071      PMCID： PMC7112147          DOI： 10.1194/jlr.C120000629

Source DB:  PubMed          Journal:  J Lipid Res        ISSN： 0022-2275            Impact factor:   5.922


× No keyword cloud information.
  7 in total

1.  Risk for diabetes mellitus in middle-aged Caucasian male participants of the PROCAM study: implications for the definition of impaired fasting glucose by the American Diabetes Association. Prospective Cardiovascular Münster.

Authors:  A von Eckardstein; H Schulte; G Assmann
Journal:  J Clin Endocrinol Metab       Date:  2000-09       Impact factor: 5.958

2.  HDL Cholesterol and Risk of Type 2 Diabetes: A Mendelian Randomization Study.

Authors:  Christiane L Haase; Anne Tybjærg-Hansen; Børge G Nordestgaard; Ruth Frikke-Schmidt
Journal:  Diabetes       Date:  2015-05-13       Impact factor: 9.461

3.  Apolipoprotein A-I improves pancreatic β-cell function independent of the ATP-binding cassette transporters ABCA1 and ABCG1.

Authors:  Liming Hou; Shudi Tang; Ben J Wu; Kwok-Leung Ong; Marit Westerterp; Philip J Barter; Blake J Cochran; Fatiha Tabet; Kerry-Anne Rye
Journal:  FASEB J       Date:  2019-04-10       Impact factor: 5.191

4.  Beta-cell ABCA1 influences insulin secretion, glucose homeostasis and response to thiazolidinedione treatment.

Authors:  Liam R Brunham; Janine K Kruit; Terry D Pape; Jenelle M Timmins; Anne Q Reuwer; Zainisha Vasanji; Brad J Marsh; Brian Rodrigues; James D Johnson; John S Parks; C Bruce Verchere; Michael R Hayden
Journal:  Nat Med       Date:  2007-02-18       Impact factor: 53.440

5.  Insulin-secreting beta-cell dysfunction induced by human lipoproteins.

Authors:  Marc-Estienne Roehrich; Vincent Mooser; Vincent Lenain; Joachim Herz; Johannes Nimpf; Salman Azhar; Martine Bideau; Alessandro Capponi; Pascal Nicod; Jacques-Antoine Haefliger; Gérard Waeber
Journal:  J Biol Chem       Date:  2003-02-18       Impact factor: 5.157

6.  Novel formulation of a reconstituted high-density lipoprotein (CSL112) dramatically enhances ABCA1-dependent cholesterol efflux.

Authors:  Svetlana Diditchenko; Andreas Gille; Ingo Pragst; Dominik Stadler; Marcel Waelchli; Ross Hamilton; Andrew Leis; Samuel D Wright
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-07-18       Impact factor: 8.311

7.  High-density lipoprotein modulates glucose metabolism in patients with type 2 diabetes mellitus.

Authors:  Brian G Drew; Stephen J Duffy; Melissa F Formosa; Alaina K Natoli; Darren C Henstridge; Sally A Penfold; Walter G Thomas; Nigora Mukhamedova; Barbora de Courten; Josephine M Forbes; Felicia Y Yap; David M Kaye; Gerrit van Hall; Mark A Febbraio; Bruce E Kemp; Dmitri Sviridov; Gregory R Steinberg; Bronwyn A Kingwell
Journal:  Circulation       Date:  2009-04-06       Impact factor: 29.690
  7 in total
  1 in total

1.  Associations of network-derived metabolite clusters with prevalent type 2 diabetes among adults of Puerto Rican descent.

Authors:  Danielle E Haslam; Liming Liang; Dong D Wang; Rachel S Kelly; Clemens Wittenbecher; Cynthia M Pérez; Marijulie Martínez; Chih-Hao Lee; Clary B Clish; David T W Wong; Laurence D Parnell; Chao-Qiang Lai; José M Ordovás; JoAnn E Manson; Frank B Hu; Meir J Stampfer; Katherine L Tucker; Kaumudi J Joshipura; Shilpa N Bhupathiraju
Journal:  BMJ Open Diabetes Res Care       Date:  2021-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.